Literature DB >> 9003637

Serologic markers in early stages of African horse sickness virus infection.

J L Martínez-Torrecuadrada1, M Díaz-Laviada, P Roy, C Sánchez, C Vela, J M Sánchez-Vizcaíno, J I Casal.   

Abstract

Fifteen horses were experimentally infected with African horse sickness virus (AHSV) serotype 4. To learn more about the time course of production and specificity of AHSV-specific antibodies, sera were analyzed by immunoblot analysis. Only animals that survived for more than 9 days were able to develop a humoral immune response detectable by immunoblotting. The earliest serological markers corresponded mainly to VP5, VP6, and NS2 and to a lesser extent to VP3, NS1, and NS3. Neutralizing antibodies to VP2 were not detected by immunoblotting, suggesting that they are mostly conformation dependent. VP7-specific antibodies were detected later in infection. These results make NS2 and VP6 the most attractive candidates for the rapid diagnosis of the infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9003637      PMCID: PMC229621          DOI: 10.1128/jcm.35.2.531-535.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Identification of bluetongue virus VP6 protein as a nucleic acid-binding protein and the localization of VP6 in virus-infected vertebrate cells.

Authors:  P Roy; A Adachi; T Urakawa; T F Booth; C P Thomas
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

Review 2.  African horse sickness: transmission and epidemiology.

Authors:  P S Mellor
Journal:  Vet Res       Date:  1993       Impact factor: 3.683

3.  The use of African horse sickness virus NS3 protein, expressed in bacteria, as a marker to differentiate infected from vaccinated horses.

Authors:  M D Laviada; P Roy; J M Sánchez-Vizcaíno; J I Casal
Journal:  Virus Res       Date:  1995-10       Impact factor: 3.303

4.  Full protection against African horsesickness (AHS) in horses induced by baculovirus-derived AHS virus serotype 4 VP2, VP5 and VP7.

Authors:  J L Martínez-Torrecuadrada; M Díaz-Laviada; P Roy; C Sánchez; C Vela; J M Sánchez-Vizcaíno; J I Casal
Journal:  J Gen Virol       Date:  1996-06       Impact factor: 3.891

5.  Characterization and cloning of the African horsesickness virus genome.

Authors:  C W Bremer; H Huismans; A A Van Dijk
Journal:  J Gen Virol       Date:  1990-04       Impact factor: 3.891

6.  Baculovirus expression of non-structural protein NS2 and core protein VP7 of African horsesickness virus serotype 3 and their use as antigens in an indirect ELISA.

Authors:  C W Bremer; D H du Plessis; A A van Dijk
Journal:  J Virol Methods       Date:  1994-07       Impact factor: 2.014

7.  Temporal development of bluetongue virus protein-specific antibody in sheep following natural infection.

Authors:  M A Adkison; J L Stott; B I Osburn
Journal:  Vet Microbiol       Date:  1988-03       Impact factor: 3.293

8.  Characterization of African horsesickness virus serotype 4-induced polypeptides in Vero cells and their reactivity in Western immunoblotting.

Authors:  M D Laviada; M Arias; J M Sánchez-Vizcaíno
Journal:  J Gen Virol       Date:  1993-01       Impact factor: 3.891

9.  Expression and characterization of the two outer capsid proteins of African horsesickness virus: the role of VP2 in virus neutralization.

Authors:  J L Martinez-Torrecuadrada; H Iwata; A Venteo; I Casal; P Roy
Journal:  Virology       Date:  1994-07       Impact factor: 3.616

Review 10.  African horse sickness virus structure.

Authors:  P Roy; P P Mertens; I Casal
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1994 Aug-Nov       Impact factor: 2.268

View more
  4 in total

1.  Sero-epidemioloical survey on African horse sickness virus among horses in Khartoum State, Central Sudan.

Authors:  Siham T Karamalla; Ahmed I Gubran; Ibrahim A Adam; Tamadur M Abdalla; Reem O Sinada; Eltahir M Haroun; Imadeldin E Aradaib
Journal:  BMC Vet Res       Date:  2018-08-01       Impact factor: 2.741

2.  B-cell epitopes of African horse sickness virus serotype 4 recognised by immune horse sera.

Authors:  Evans M Mathebula; Frederika E Faber; Wouter Van Wyngaardt; Antoinette Van Schalkwyk; Alri Pretorius; Jeanni Fehrsen
Journal:  Onderstepoort J Vet Res       Date:  2017-02-24       Impact factor: 1.792

3.  Re-parameterization of a mathematical model of African horse sickness virus using data from a systematic literature search.

Authors:  Emma L Fairbanks; Marnie L Brennan; Peter P C Mertens; Michael J Tildesley; Janet M Daly
Journal:  Transbound Emerg Dis       Date:  2022-01-12       Impact factor: 4.521

4.  Induction of antibody responses to African horse sickness virus (AHSV) in ponies after vaccination with recombinant modified vaccinia Ankara (MVA).

Authors:  Rachael Chiam; Emma Sharp; Sushila Maan; Shujing Rao; Peter Mertens; Barbara Blacklaws; Nick Davis-Poynter; James Wood; Javier Castillo-Olivares
Journal:  PLoS One       Date:  2009-06-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.